Show simple item record

dc.contributor.authorPatel, Mitesh
dc.date.accessioned2019-01-11T12:33:15Z
dc.date.available2019-01-11T12:33:15Z
dc.date.issued2017-09-01
dc.identifier.citationPatel, M. (2017) 'Intratympanic corticosteroids in Ménière's disease: A mini-review', Journal of Otology. 12(3) pp. 117–124 doi 10.1016/j.joto.2017.06.002en
dc.identifier.issn1672-2930en
dc.identifier.doi10.1016/j.joto.2017.06.002
dc.identifier.urihttp://hdl.handle.net/2436/622054
dc.description.abstractThis article reviews the effectiveness of intratympanic corticosteroids for vertigo control in Ménière's disease at 2-years follow-up according to the guidelines expressed by the American Academy of Otolaryngology-Head & Neck Surgery. Despite the increased use of intratympanic corticosteroids for vertigo control in Ménière's disease there is debate as to their effectiveness, particularly compared to gentamicin. Even so, after just a single course of injections, corticosteroids can reliably provide complete vertigo control (Class A) at 2-years in about 50% of cases as indicated in a recent double-blind randomized controlled clinical trial (Patel et al., 2016). But the effectiveness of intratympanic corticosteroids truly increases when treatment is provided ‘as-needed’, whereby complete vertigo control is established in up to 91% of cases. On the basis of available literature, there is good evidence to recommend the use of intratympanic steroid treatment for vertigo control in Ménière's disease, but patients must be monitored for non-response. The rationale for treating patients as-needed and the possible reasons for corticosteroid non-response are discussed.en
dc.formatapplication/PDFen
dc.language.isoenen
dc.publisherElsevieren
dc.relation.urlhttps://www.sciencedirect.com/science/article/pii/S1672293017300302?via%3Dihuben
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/us/*
dc.subjectcorticosteroiden
dc.subjectdexamethasoneen
dc.subjectintratympanicen
dc.subjectmethylprednisoloneen
dc.subjectMeniere's diseaseen
dc.titleIntratympanic corticosteroids in Ménière's disease: A mini-reviewen
dc.typeJournal article
dc.identifier.journalJournal of Otologyen
dc.date.accepted2017-06-01
rioxxterms.funderUniversity of Wolverhamptonen
rioxxterms.identifier.projectUOW110119MPen
rioxxterms.versionAMen
rioxxterms.licenseref.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/en
rioxxterms.licenseref.startdate2019-01-11en
dc.source.volume12
dc.source.issue3
dc.source.beginpage117
dc.source.endpage124
refterms.dateFCD2019-01-11T12:33:16Z
refterms.versionFCDAM
refterms.dateFOA2019-01-11T12:33:16Z


Files in this item

Thumbnail
Name:
Publisher version
Thumbnail
Name:
Steroid Review.pdf
Size:
318.5Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivs 3.0 United States
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs 3.0 United States